Citadel Advisors
GNFT

Citadel Advisors’s Genfit GNFT Stock Holding History

Citadel Advisors’s Portfolio GNFT Stock Details GNFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,763
Closed -$67.9K – 13280
2025
Q2 		$67.9K Buy
18,763
+6,432
+52% +$25.4K ﹤0.01% 11613
2025
Q1 		$44.3K Buy
+12,331
New +$45.4K ﹤0.01% 12432
2024
Q2 		– Sell
-16,833
Closed -$59.9K – 14694
2024
Q1 		$59.9K Buy
+16,833
New +$62.2K ﹤0.01% 12000
2023
Q2 		– Sell
-19,592
Closed -$79K – 14664
2023
Q1 		$79K Sell
19,592
-1,973
-9% -$8.47K ﹤0.01% 11578
2022
Q4 		$94K Sell
21,565
-13,754
-39% -$53.1K ﹤0.01% 11310
2022
Q3 		$129K Buy
35,319
+22,786
+182% +$95.2K ﹤0.01% 10859
2022
Q2 		$40K Buy
+12,533
New +$45.2K ﹤0.01% 12062
2021
Q4 		– Sell
-23,627
Closed -$87K – 14171
2021
Q3 		$87K Sell
23,627
-11,327
-32% -$43.2K ﹤0.01% 13000
2021
Q2 		$135K Buy
34,954
+267
+0.8% +$1.12K ﹤0.01% 12615
2021
Q1 		$160K Buy
+34,687
New +$179K ﹤0.01% 11966

Other funds holding GNFT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Citadel Advisors's GNFT Position: Q3 2025 in Review

Citadel Advisors sold out of Genfit (GNFT) in Q3 2025, closing a stake of 18,763 shares — an estimated $67.9K sold.

Citadel Advisors first reported a position in GNFT in Q1 2021 and held it in 10 quarters. The position peaked at $160K in Q1 2021. 6 funds tracked by Wall St. Rank hold GNFT as of Q3 2025.

  • Citadel Advisors reported no remaining Genfit position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 18,763 Genfit shares in Q3 2025, an estimated $67.9K.
  • Citadel Advisors first reported a position in Genfit in Q1 2021 and held it in 10 quarters.
  • Citadel Advisors's Genfit position peaked at $160K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Genfit as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.